Risk Assessment of Long-Haul Truck Drivers
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
![](https://webarchive.library.unt.edu/web/20130302094057im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
International studies have repeatedly documented a substantial prevalence of sexual risk behaviors and high rates of human immunodeficiency virus (HIV) and other sexually transmitted infections (STI) ranging from 5%-56% amongst long-distance truck drivers ("truckers") living in diverse international settings including India, Bangladesh, South Africa, China, Laos and Thailand. The prevalence of sexual risk factors and STI/HIV in US drivers is unknown. This proposal will provide both qualitative and quantitative data on HIV risk behaviors by interviewing and testing truckers working for established long-distance trucking firms, the sector which accounts for most of the jobs in the trucking and warehousing industry in the United States. The data obtained from this study will be used to inform the development of an HIV prevention intervention for long-haul truck drivers.
Condition |
---|
Gonorrhea Chlamydia Infections Hepatitis B Hepatitis C Diabetes Mellitus Hypertension Obesity HIV Infections Hyperlipidemia |
Study Type: | Observational |
Study Design: | Time Perspective: Cross-Sectional |
Official Title: | Risk Assessment of Long-Haul Truck Drivers |
Estimated Enrollment: | 337 |
Study Start Date: | September 2005 |
Estimated Study Completion Date: | August 2010 |
Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
The study proposed in this R34 application will address the following specific aims:
Specific Aim 1. To perform focus groups and in-depth interviews with long-haul truck drivers to guide development of both a behavioral risk assessment instrument and an acceptable HIV/STI screening protocol for long-haul truckers.
Specific Aim 2. To perform in-depth interviews with trucking industry executives to determine barriers to routine HIV/STI assessment and screening of their employees.
Specific Aim 3. To perform a pilot phase with a subsample of long-haul truck drivers characterized by the following steps: TTM-based "cognitive interviews" (N=5); pilot testing of the survey and biomedical screening protocol (N=15); and a follow-up focus group (N=8)
Specific Aim 4. To assess a sample of (N=300) truck drivers for general health and sexual risk behaviors using the adapted theory-based survey and to determine the prevalence of hepatitis B, hepatitis C, hypertension, hyperlipidemia, diabetes and obesity, HIV, N. gonorrhoeae, and C. trachomatis
![](https://webarchive.library.unt.edu/web/20130302094057im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
American long-haul truck drivers affiliated with participating companies or presenting as clients at participating truck stops.
Inclusion Criteria:
- Long-haul truck driver as defined as a driver, part-time or full-time, who drives a truck across state lines (interstate)
- English speaking
- Age 21 or greater
- Willing to participate
- Able to provide written informed consent
Exclusion Criteria:
- Does not fit definition of truck driver in inclusion criteria #1
- Unwilling to participate
- Unwilling or unable to provide informed consent
- Unable to understand or speak English
- Age < 21 years
![](https://webarchive.library.unt.edu/web/20130302094057im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Contact: Laura H Bachmann, MD, MPH | 336-716-3100 | lbachman@wfubmc.edu |
United States, North Carolina | |
Wake Forest University Health Sciences | Recruiting |
Winston-Salem, North Carolina, United States, 27157 | |
Principal Investigator: Laura H Bachmann, MD, MPH |
Principal Investigator: | Laura H Bachmann, MD, MPH | Wake Forest University |
![](https://webarchive.library.unt.edu/web/20130302094057im_/http://clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
No publications provided
Responsible Party: | Laura Hinkle Bachmann, MD, MPH, Wake Forest University Health Sciences |
ClinicalTrials.gov Identifier: | NCT00381992 History of Changes |
Other Study ID Numbers: | F060815005, 5R34MH073411-03 |
Study First Received: | September 26, 2006 |
Last Updated: | January 14, 2010 |
Health Authority: | United States: Institutional Review Board |
Keywords provided by Wake Forest University:
sexual risk behavior diabetes mellitus hypertension obesity |
human immunodeficiency virus hyperlipidemia chlamydia |
Additional relevant MeSH terms:
HIV Infections Acquired Immunodeficiency Syndrome Chlamydia Infections Diabetes Mellitus Gonorrhea Hepatitis Hepatitis A Hepatitis B Hepatitis C Hyperlipidemias Hypertension Obesity Lentivirus Infections Retroviridae Infections RNA Virus Infections |
Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases Chlamydiaceae Infections Gram-Negative Bacterial Infections Bacterial Infections Sexually Transmitted Diseases, Bacterial Infection Genital Diseases, Male Genital Diseases, Female Glucose Metabolism Disorders Metabolic Diseases |
ClinicalTrials.gov processed this record on February 28, 2013